4//SEC Filing
COHEN MARC A 4
Accession 0001209191-21-012339
CIK 0001662579other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:15 PM ET
Size
9.3 KB
Accession
0001209191-21-012339
Insider Transaction Report
Form 4
COHEN MARC A
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2021-02-18$2.11/sh+536$1,131→ 5,566 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-18−536→ 3,209 totalExercise: $2.11Exp: 2026-07-12→ Common Stock (536 underlying)
Holdings
- 1,852,207(indirect: See Footnote)
Common Stock
- 2,484,425(indirect: By Cobro Ventures Opportunity Fund, L.P.)
Common Stock
Footnotes (3)
- [F1]Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F2]Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.
- [F3]Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such date.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001132945
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:15 PM ET
- Size
- 9.3 KB